Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INFRATIL LIMITED. Director's Dealing 2021

May 20, 2021

65106_rns_2021-05-20_5067826c-2f46-4e50-98a9-083a3d1578c1.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Infratil Limited
Date this disclosure made: 20-May-21
Date of last disclosure: 7-Jul-20
Director or senior managergiving disclosure
Full name(s): Mark Tume
Name of listed issuer: Infratil Limited (IFT)
Name of related body corporate (ifapplicable):
Position held in listed issuer: Chairman
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:
Ordinaryshares in IFT
Nature of the affected relevant interest(s):
Registered holder and beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal:
49,132
Number held in class after acquisition or disposal:
59,132
Current registered holder(s):
Registered holder(s) once transfers are registered:
Mark Tume, Helen Joan Tume, Lisle
AntonyMcErland and Renee Dina Tume
Details of transactions giving rise to acquisition or disposal
Ordinaryshares in IFT
Registered holder and beneficial owner
49,132
59,132
Mark Tume, Helen Joan Tume, Lisle
AntonyMcErland and Renee Dina Tume
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates: 2
Date oftransaction: 30/03/2021 -31/03/2021
Nature of transaction: On-market acquisition
Name ofany otherparty orparties to the transaction(if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value,describe the consideration:
69,989.72
Numberof financialproducts towhichthe transaction related: 10,000
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period: No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod:
Date of theprior written clearance(if any):
Summary of other relevant interests after acquisition or disposal:
Class ofquotedfinancialproducts:
Nature of relevantinterest:
For that relevant interest,-
Number heldinclass:
Currentregisteredholder(s):
For a derivative relevant interest,-
Type ofderivative:
Ordinaryshares in IFT
Non-beneficial
7,389
WelltestLtd
Type ofderivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: 20-May-20 Name and title of authorised person: Nicholas Lough, Company Secretary

==> picture [459 x 143] intentionally omitted <==